Calvin Q. Pan

7.6k total citations · 1 hit paper
130 papers, 3.0k citations indexed

About

Calvin Q. Pan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Calvin Q. Pan has authored 130 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Epidemiology, 101 papers in Hepatology and 20 papers in Infectious Diseases. Recurrent topics in Calvin Q. Pan's work include Hepatitis B Virus Studies (91 papers), Hepatitis C virus research (83 papers) and Liver Disease Diagnosis and Treatment (67 papers). Calvin Q. Pan is often cited by papers focused on Hepatitis B Virus Studies (91 papers), Hepatitis C virus research (83 papers) and Liver Disease Diagnosis and Treatment (67 papers). Calvin Q. Pan collaborates with scholars based in United States, China and Canada. Calvin Q. Pan's co-authors include Zhongping Duan, Huaibin Zou, Guorong Han, Yunliu Chen, Ke‐Qin Hu, Myron J. Tong, Erhei Dai, Yuming Wang, Hua Zhang and Hongxiu Jiang and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Calvin Q. Pan

119 papers receiving 2.9k citations

Hit Papers

Tenofovir to Prevent Hepatitis B Transmission in Mothers ... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
    2016 386 citations Calvin Q. Pan, Zhongping Duan et al. profile →

Peers

Calvin Q. Pan
Justina Groeger United States
Yusuke Shimakawa France
Małgorzata Pawłowska Poland
Giovanni Battista Gaeta Italy
C Wendy Spearman South Africa
Tzee‐Chung Wu Taiwan
Gabriella Verucchi Italy
Premashis Kar India
Barbara McGovern United States
Mark Sonderup South Africa
Justina Groeger United States
Calvin Q. Pan
Citations per year, relative to Calvin Q. Pan Calvin Q. Pan (= 1×) peers Justina Groeger

Countries citing papers authored by Calvin Q. Pan

Since Specialization
Citations

This map shows the geographic impact of Calvin Q. Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Q. Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Q. Pan more than expected).

Fields of papers citing papers by Calvin Q. Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin Q. Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Q. Pan. The network helps show where Calvin Q. Pan may publish in the future.

Co-authorship network of co-authors of Calvin Q. Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin Q. Pan. A scholar is included among the top collaborators of Calvin Q. Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin Q. Pan. Calvin Q. Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuanyuan, Yifan Xu, Yingying Zhao, et al.. (2025). Featured intestinal microbiota associated with hepatocellular carcinoma in various liver disease states. Frontiers in Immunology. 16. 1674838–1674838.
2.
3.
Lu, Yanjun, Yiwen Yang, Lijie Zhang, et al.. (2025). Determination of PSA by a label-free fluorescent aptasensor based on the on and off of the AIEE effect. Talanta. 293. 128093–128093. 1 indexed citations
4.
Pan, Calvin Q., et al.. (2025). Biodegradable plastics in soil: a significant gap from microplastics to nanoplastics and oligomers. Environmental Science Nano. 12(4). 2208–2228. 4 indexed citations
5.
Ghany, Marc G., Calvin Q. Pan, Anna S. Lok, et al.. (2025). AASLD IDSA Practice Guideline on treatment of chronic hepatitis B. Hepatology. 83(4). 974–997. 3 indexed citations
6.
Zhu, Lin, et al.. (2025). Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD. Gastroenterology report. 13. goaf018–goaf018.
7.
8.
Pan, Calvin Q., Erhei Dai, Hua Zhang, et al.. (2024). Tenofovir and Hepatitis B Virus Transmission During Pregnancy. JAMA. 333(5). 390–390. 6 indexed citations
9.
Deng, You, Huiling Xiang, Yuemin Nan, et al.. (2024). Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis. JHEP Reports. 6(7). 101091–101091. 7 indexed citations
10.
Wang, Peng, Calvin Q. Pan, Yali Liu, & Jing Zhang. (2023). The evolving role of non-invasive assessment for liver fibrosis. Gastroenterology report. 12. goae080–goae080. 1 indexed citations
11.
Fung, Scott, Calvin Q. Pan, Grace Lai–Hung Wong, et al.. (2023). Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary Pharmacology & Therapeutics. 59(2). 217–229. 7 indexed citations
12.
Razavi‐Shearer, Devin, Ivane Gamkrelidze, Calvin Q. Pan, et al.. (2023). The impact of immigration on hepatitis B burden in the United States: a modelling study. The Lancet Regional Health - Americas. 22. 100516–100516. 14 indexed citations
13.
14.
Podlaha, Ondřej, Edward Gane, Maurizia Rossana Brunetto, et al.. (2019). Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients. Scientific Reports. 9(1). 10529–10529. 15 indexed citations
15.
Tong, Myron J., Calvin Q. Pan, David Lu, et al.. (2018). An expert consensus for the management of chronic hepatitis B in Asian Americans. Alimentary Pharmacology & Therapeutics. 47(8). 1181–1200. 40 indexed citations
16.
Cao, Weihua, Minghui Li, Calvin Q. Pan, et al.. (2018). Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy. Journal of Interferon & Cytokine Research. 38(5). 197–205. 13 indexed citations
17.
Xie, Wen, Qi Wang, Yuanjiao Gao, & Calvin Q. Pan. (2018). Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report. BMC Gastroenterology. 18(1). 142–142. 10 indexed citations
18.
Pan, Calvin Q., Zhongping Duan, Erhei Dai, et al.. (2016). Tenofovir to Prevent Hepatitis B Transmission in Mothers With High Viral Load. Obstetrical & Gynecological Survey. 71(10). 586–587. 3 indexed citations
19.
Lok, Anna S., Calvin Q. Pan, Steven-Huy Han, et al.. (2016). Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. Journal of Hepatology. 65(3). 509–516. 141 indexed citations
20.
Pan, Calvin Q. & Ponni Perumalswami. (2010). Pregnancy-Related Liver Diseases. Clinics in Liver Disease. 15(1). 199–208. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justina Groeger Breakdown of academic impact, for papers by Yusuke Shimakawa Breakdown of academic impact, for papers by Małgorzata Pawłowska Breakdown of academic impact, for papers by Giovanni Battista Gaeta Breakdown of academic impact, for papers by C Wendy Spearman Breakdown of academic impact, for papers by Tzee‐Chung Wu Breakdown of academic impact, for papers by Gabriella Verucchi Breakdown of academic impact, for papers by Premashis Kar Breakdown of academic impact, for papers by Barbara McGovern Breakdown of academic impact, for papers by Mark Sonderup
Rankless by CCL
2026